EVAL Trademark

Trademark Overview


On Tuesday, July 16, 2024, a trademark application was filed for EVAL with the United States Patent and Trademark Office. The USPTO has given the EVAL trademark a serial number of 98650106. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, April 11, 2025. This trademark is owned by EVAL Health LLC. The EVAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a Service (PaaS) featuring HIPAA-compliant computer software platforms using artificial intelligence and machine learning specifically designed for healthcare providers to translate peer-reviewed medical research into no-code clinical applications and patient-specific decision support tools for use at the point of care in clinical settings; Software as a Service (SaaS) services featuring secure, regulatory-compliant web-based and mobile software for providing clinicians and healthcare organizations with access to specialized clinical decision support tools to evaluate medical conditions, recommend evidence-based treatments, and implement medically published guidelines, all derived from standardized clinical research data with no coding required by clinical teams, for use within healthcare delivery environments.
eval

General Information


Serial Number98650106
Word MarkEVAL
Filing DateTuesday, July 16, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, April 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of A circle with the sigma symbol Σ inside the circle and the word EVAL after the circle.
Goods and ServicesPlatform as a Service (PaaS) featuring HIPAA-compliant computer software platforms using artificial intelligence and machine learning specifically designed for healthcare providers to translate peer-reviewed medical research into no-code clinical applications and patient-specific decision support tools for use at the point of care in clinical settings; Software as a Service (SaaS) services featuring secure, regulatory-compliant web-based and mobile software for providing clinicians and healthcare organizations with access to specialized clinical decision support tools to evaluate medical conditions, recommend evidence-based treatments, and implement medically published guidelines, all derived from standardized clinical research data with no coding required by clinical teams, for use within healthcare delivery environments.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2024
Primary Code042
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

Trademark Owner History


Party NameEVAL Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSaint Paul, MN 55129

Trademark Events


Event DateEvent Description
Tuesday, July 16, 2024NEW APPLICATION ENTERED
Tuesday, July 16, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, February 5, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 6, 2025ASSIGNED TO EXAMINER
Thursday, February 6, 2025NON-FINAL ACTION WRITTEN
Wednesday, April 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 11, 2025SUSPENSION LETTER WRITTEN
Friday, April 11, 2025LETTER OF SUSPENSION E-MAILED
Friday, April 11, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 6, 2025NON-FINAL ACTION E-MAILED